Xeris Biopharma Holdings, Inc. (XERS)
7.46
-0.21
(-2.74%)
USD |
NASDAQ |
Sep 11, 13:48
Xeris Biopharma Holdings Gross Profit (TTM) : 279.54M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 279.54M |
| March 31, 2026 | 259.60M |
| December 31, 2025 | 238.43M |
| September 30, 2025 | 214.19M |
| June 30, 2025 | 191.48M |
| March 31, 2025 | 172.12M |
| December 31, 2024 | 155.40M |
| September 30, 2024 | 141.59M |
| June 30, 2024 | 141.04M |
| March 31, 2024 | 131.22M |
| December 31, 2023 | 124.43M |
| September 30, 2023 | 114.46M |
| June 30, 2023 | 98.80M |
| March 31, 2023 | 88.85M |
| December 31, 2022 | 76.77M |
| September 30, 2022 | 68.82M |
| June 30, 2022 | 54.58M |
| March 31, 2022 | 42.00M |
| December 31, 2021 | 35.04M |
| Date | Value |
|---|---|
| September 30, 2021 | 22.62M |
| June 30, 2021 | 21.43M |
| March 31, 2021 | 16.64M |
| December 31, 2020 | 10.19M |
| September 30, 2020 | 6.302M |
| June 30, 2020 | -0.057M |
| March 31, 2020 | -0.395M |
| December 31, 2019 | 0.041M |
| September 30, 2019 | 0.787M |
| June 30, 2019 | 1.39M |
| March 31, 2019 | 2.059M |
| December 31, 2018 | 2.134M |
| September 30, 2018 | 1.920M |
| June 30, 2018 | 1.514M |
| March 31, 2018 | 1.300M |
| December 31, 2017 | 1.427M |
| September 30, 2017 | 1.014M |
| June 30, 2017 | 0.844M |
| March 31, 2017 | 0.316M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Zevra Therapeutics, Inc. | 128.53M |
| Aclaris Therapeutics, Inc. | 1.06M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |
| Veru, Inc. | -0.113M |